Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) EBITDA Margin (2023 - 2025)

Bioharvest Sciences has reported EBITDA Margin over the past 3 years, most recently at 12.36% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 1081.0% year-over-year to 12.36%; the TTM value through Dec 2025 reached 16.16%, up 1159.0%, while the annual FY2025 figure was 16.16%, 1159.0% up from the prior year.
  • EBITDA Margin was 12.36% for Q4 2025 at Bioharvest Sciences, down from 10.15% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 104.55% in Q2 2023 and bottomed at 384.58% in Q4 2023.
  • The 3-year median for EBITDA Margin is 21.87% (2025), against an average of 35.93%.
  • The widest YoY moves for EBITDA Margin: up 36140bps in 2024, down -13401bps in 2024.
  • Over 3 years, EBITDA Margin stood at 384.58% in 2023, then skyrocketed by 94bps to 23.18% in 2024, then surged by 47bps to 12.36% in 2025.
  • The last three reported values for EBITDA Margin were 12.36% (Q4 2025), 10.15% (Q3 2025), and 21.32% (Q2 2025) per Business Quant data.